Wu Y - Search Results

1

Oncolytic Peptide-Nanoplatform Drives Oncoimmune Response and Reverses Adenosine-Induced Immunosuppressive Tumor Microenvironment.

Wu Y, Lin JY, Zhou YD, Liu HJ, Lu SX, Zhang XK, Guan YY, Nagle DG, Zhang WD, Chen HZ, Luan X. Wu Y, et al. Adv Healthc Mater. 2024 Oct;13(26):e2303445. doi: 10.1002/adhm.202303445. Epub 2024 Jul 9. Adv Healthc Mater. 2024. PMID: 38290499

2

[Stapled anoplin peptide combined with photothermal therapy enhances oncolytic immunotherapy of triple-negative breast cancer].

Gao WD, Liu XX, Yang T, Lin JY, Song YX, Lu SX, Zhang XK, Wu Y, Luan X, Zhang WD. Gao WD, et al. Among authors: wu y. Zhongguo Zhong Yao Za Zhi. 2023 Sep;48(18):4981-4992. doi: 10.19540/j.cnki.cjcmm.20230510.302. Zhongguo Zhong Yao Za Zhi. 2023. PMID: 37802840 Chinese.

3

In Silico Discovery of Stapled Peptide Inhibitor Targeting the Nur77-PPARγ Interaction and Its Anti-Breast-Cancer Efficacy.

Bian H, Liang X, Lu D, Lin J, Lu X, Jin J, Zhang L, Wu Y, Chen H, Zhang W, Luan X. Bian H, et al. Among authors: wu y. Adv Sci (Weinh). 2024 Jul;11(26):e2308435. doi: 10.1002/advs.202308435. Epub 2024 Apr 29. Adv Sci (Weinh). 2024. PMID: 38682467 Free PMC article.

4

Seleno-amino Acid Metabolism Reshapes the Tumor Microenvironment: from Cytotoxicity to Immunotherapy.

Liang R, Cheng A, Lu S, Zhang X, Ren M, Lin J, Wu Y, Zhang W, Luan X. Liang R, et al. Among authors: wu y. Int J Biol Sci. 2024 May 5;20(7):2779-2789. doi: 10.7150/ijbs.95484. eCollection 2024. Int J Biol Sci. 2024. PMID: 38725849 Free PMC article. Review.

5

Insights into therapeutic peptides in the cancer-immunity cycle: Update and challenges.

Zhang X, Wu Y, Lin J, Lu S, Lu X, Cheng A, Chen H, Zhang W, Luan X. Zhang X, et al. Among authors: wu y. Acta Pharm Sin B. 2024 Sep;14(9):3818-3833. doi: 10.1016/j.apsb.2024.05.013. Epub 2024 May 13. Acta Pharm Sin B. 2024. PMID: 39309492 Free PMC article. Review.

6

Self-assembled PROTACs enable protein degradation to reprogram the tumor microenvironment for synergistically enhanced colorectal cancer immunotherapy.

Lu X, Jin J, Wu Y, Lin J, Zhang X, Lu S, Zhang J, Zhang C, Ren M, Chen H, Zhang W, Luan X. Lu X, et al. Among authors: wu y. Bioact Mater. 2024 Sep 25;43:255-272. doi: 10.1016/j.bioactmat.2024.09.022. eCollection 2025 Jan. Bioact Mater. 2024. PMID: 39386219 Free PMC article.

7

Toosendanin: upgrade of an old agent in cancer treatment.

Li S, Xiong Q, Shen Y, Lin J, Zhang L, Wu Y, Jin J, Luan X. Li S, et al. Among authors: wu y. Chin J Nat Med. 2024 Oct;22(10):887-899. doi: 10.1016/S1875-5364(24)60693-X. Chin J Nat Med. 2024. PMID: 39428181 Review.

8

Decoding β-catenin associated protein-protein interactions: Emerging cancer therapeutic opportunities.

Yan Y, Gong Y, Liang X, Xiong Q, Lin J, Wu Y, Zhang L, Chen H, Jin J, Luan X. Yan Y, et al. Among authors: wu y. Biochim Biophys Acta Rev Cancer. 2024 Dec 4;1880(1):189232. doi: 10.1016/j.bbcan.2024.189232. Online ahead of print. Biochim Biophys Acta Rev Cancer. 2024. PMID: 39643250 Review.

9

A PROTAC peptide induces durable β-catenin degradation and suppresses Wnt-dependent intestinal cancer.

Liao H, Li X, Zhao L, Wang Y, Wang X, Wu Y, Zhou X, Fu W, Liu L, Hu HG, Chen YG. Liao H, et al. Among authors: wu y. Cell Discov. 2020 Jun 9;6:35. doi: 10.1038/s41421-020-0171-1. eCollection 2020. Cell Discov. 2020. PMID: 32550000 Free PMC article.

10

Total Synthesis and Antibacterial Study of Cyclohexapeptides Desotamide B, Wollamide B and Their Analogs.

Chen YX, Liu C, Liu N, Wu Y, Zhao QJ, Hu HG, Li X, Zou Y. Chen YX, et al. Among authors: wu y. Chem Biodivers. 2018 Jan;15(1). doi: 10.1002/cbdv.201700414. Epub 2017 Dec 27. Chem Biodivers. 2018. PMID: 29125222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85,378 results

Search Page

Filters